OneMedNet Corporation will showcase its next‑generation iRWD™ platform at the ISPOR Europe conference, which runs from November 9‑12. The demonstration will highlight the platform’s integration with Palantir Technologies’ Foundry ecosystem, enabling live data feeds and AI‑driven conversational search for regulatory‑grade, de‑identified real‑world imaging data.
The partnership with Palantir is a key enabler for OneMedNet’s platform, providing a robust data infrastructure and advanced AI capabilities that allow life‑science customers to access high‑quality imaging data on demand. By embedding Palantir’s Foundry, the platform can ingest, harmonize, and secure multimodal data streams, delivering faster, more consistent insights for drug development, device validation, and AI model training.
OneMedNet’s announcement comes at a time when the company’s financials are under pressure. Trailing‑twelve‑month revenue stands at $0.46 million, and gross profit margins are a negative 121 percent, with a current ratio of 0.37. The shift to a subscription‑based iRWD model is intended to replace legacy BEAM services and create a more predictable, recurring revenue stream that can support the company’s long‑term growth and improve its balance sheet.
The real‑world data market is expanding rapidly. In 2025 the market is valued at $2.38 billion and is projected to reach $6.1 billion by 2032, growing at a CAGR of 14.4 percent. The broader AI‑enabled healthcare sector is expected to reach $868 billion by 2030. OneMedNet’s platform positions it to capture a share of this growth by addressing the critical need for secure, high‑quality clinical data.
CEO Aaron Green emphasized the strategic importance of the partnership, stating, “Palantir’s Foundry and AIP platform supercharge our ability to deliver regulatory‑grade, multimodal RWD with unparalleled speed, consistency, traceability, and security.” He added that the iRWD platform marks a significant leap forward in how life sciences and AI innovators discover, access, and operationalize real‑world data from vast clinical datasets.
By demonstrating the platform at ISPOR Europe, OneMedNet aims to accelerate customer acquisition, validate its new recurring‑revenue model, and strengthen its competitive position in the growing real‑world data market. The event signals the company’s commitment to transforming its business model and leveraging advanced AI to meet the evolving needs of the life‑sciences industry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.